Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
Transfusion|February 1, 1991
Inactivation of viruses in blood with aluminum phthalocyanine derivativesB Horowitz, B Williams, S Rywkin, et al.Experimental Parasitology|August 1, 1995
Onchocerca volvulus: a comparative study of in vitro neutrophil killing of microfilariae and humoral responses in infected and endemic normalsE H Johnson, S Lustigman, P H Kass, et al.Blood|February 1, 1992
Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasmaB Horowitz, R Bonomo, A M Prince, et al.Biochemical Pharmacology|August 26, 1998
Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)L Andrus, P Szabo, R W Grady, et al.The Journal of Infectious Diseases|September 9, 1999
Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humansA M Prince, B Brotman, D H Lee, et al.The Journal of Infectious Diseases|February 1, 1975
Hepatitis B surface antigen in blood donors: further observationsW Szmuness, R L Hirsch, A M Prince, et al.Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|June 20, 2008
Development of the International Consortium for Blood Safety (ICBS) HCV panelsS Diaz, P Liu, W L Kuhnert, et al.Vox Sanguinis|January 1, 1984
Inactivation of hepatitis B and Hutchinson strain non-A, non-B hepatitis viruses by exposure to Tween 80 and etherA M Prince, B Horowitz, B Brotman, et al.The Journal of Infectious Diseases|June 1, 1993
Patterns and prevalence of hepatitis C virus infection in posttransfusion non-A, non-B hepatitisA M Prince, B Brotman, G Inchauspé, et al.Vox Sanguinis|January 1, 1988
Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acidsB Horowitz, M P Piët, A M Prince, et al.Pageof 20